Drug Targeting Organ-Specific Strategies

196 7 Vascular Endothelium in Inflamed Tissue as a Target for Site Selective Delivery of Drugs
[97] Sudbeck EA, Liu XP, Narla RK, Mahajan S, Ghosh S, Mao C, Uckun FM, Clin. Cancer Res. 1999,
5, 1569–1582.
[98] Wasik MA, Nowak I, Zhang Q, Shaw LM, Leuk. Lymph. 1998, 28, 551–560.
[99] Wang LH, Kirken RA, Erwin RA, Yu CR, J. Immunol. 1999, 162, 3897–3904.
[100] Cronstein BN, Kimmel SC, Levin RI, Martiniuk F, Weissmann G, Proc. Natl. Acad. Sci. USA
1992, 89, 9991–9995.
[101] Didonato JA, Saatcioglu F, Karin M, Am. J. Respir. Crit. Care Med. 1996, 154, S11–S15.
[102] Brostjan C, Anrather J, Csizmadia V, Natarajan G, Winkler H, J. Immunol. 1997, 158,
3836–3844.
[103] Ardite E, Panes J, Miranda M, Salas A, Elizalde JI, Sans M, Arce Y, Bordas JM, Fernandezcheca
JC, Pique JM, Br. J. Pharmacol. 1998, 124, 431–433.
[104] Lansink M, Koolwijk P, Van Hinsberg V, Kooistra T, Blood 1998, 92, 927–938.
[105] Wolff JE, Molenkamp G, Hotfilder M, Laterra J, Klin. Padiatr. 1997, 209, 275–277.
[106] Diaz Gonzalez F, Sanchez Madrid F, Immunol. Today 1998, 19, 169–172.
[107] Sakai A, Life Sci. 1996, 58, 2377–2387.
[108] Hofbauer R, Speiser W, Kapiotis S, Life Sci. 1998, 62, 1775–1781.
[109] Pierce JW, Read MA, Ding H, Luscinskas FW, Collins T, J. Immunol. 1996, 156, 3961–3969.
[110] Xia L, Pan J, Yao L, McEver RP, Blood 1998, 91, 1625–1632.
[111] Jones MK, Wang H, Peskar BM, Levin E, Itani RM, Sarfeh IJ, Tarnawski AS, Nature Med. 1999,
5, 1418–1423.
[112] Murthy S, Murthy NS, Coppola D, Wood DL, Inflamm. Res. 1997, 46, 224–233.
[113] Bennett CF, Condon TP, Grimm S, Chan H, Chiang MY, J. Immunol. 1994, 152, 3530–3540.
[114] Bennett CF, Kornbrust D, Henry S, Stecker K, Howard R, Cooper S, Dutson S, Hall W, Jacoby
HI, J. Pharmacol. Exp. Ther. 1997, 280, 988–1000.
[115] Yacyshyn BR, BowenYacyshyn MB, Jewell L, Tami JA, Bennett CF, Kisner DL, Shanahan WR,
Gastroenterology 1998, 114, 1133–1142.
[116] Neurath MF, Pettersson S, Meyer zum Büschenfelde K-H, Strober W, Nature Med. 1996, 2,
998–1004.
[117] Akhtar S and Agrawal S, Trends Pharmacol. Sci. 1997, 18, 12–18.
[118] Jenison RD, Jennings SD, Walker DW, Bargatze RF, Parma D, Antisense Nucleic Acid Drug Dev.
1998, 8, 265–279.
[119] Peacock DJ, Banquerigo ML, Brahn E, J. Exp. Med. 1992, 175, 1135–1138.
[120] Oliver SJ, Banquerigo ML, Brahn E, Cell Immunol. 1994, 157, 291–299.
[121] Moulton KS, Heller E, Konerding MA, Flynn E, Palinski W, Folkman J, Circulation 1999, 99,
1726–1732.
[122] D’Amato RJ, Loughnan MS, Flynn E, Folkman J, Proc. Natl Acad. Sci.USA 1994, 91, 4082–4085.
[123] Moreira AL, Sampaio EP, Zmuidzinas A, Frindt P, Smith KA, Kaplan G, J. Exp. Med. 1993, 177,
1675–1680.
[124] Marriott JB, Muller G, Dalgleish AG, Immunol. Today 1999, 20, 538–540.
[125] Koch AE, Szekanecz Z, Friedman J, Haines GK, Langman CB, Bouck NP, Clin. Immunol. Immunopathol.
1998, 86, 199–208.
[126] Anonymous. SCRIP 1999, October (2477), 20.
[127] Dong QG, Bernasconi S, Lostaglio S, De Calmanovici RW, Martin Padura I, Breviario F, Garlanda
C, Ramponi S, Mantovani A, Vecchi A, Arterioscler. Thromb. Vasc. Biol. 1997, 17,
1599–1604.
[128] van Leeuwen EBM, Veenstra R, van Wijk R, Molema G, Hoekstra A, Ruiters MHJ, van der Meer
J, Blood Coagul. Fibrinol. 2000, 11, 15–25.
[129] Lidington EA, Moyes DL, McCormack AM, Rose ML, Transpl. Immunol. 1999, 7, 239–246.
[130] Tamaru M, Tomura K, Sakamoto S, Tezuka K, Tamatani T, Narumi S, Arterioscler. Thromb.
Vasc. Biol. 1998, 18, 1292–1303.
[131] Haraldsen G, Kvale D, Lien B, Farstad IN, Brandtzaeg P, J. Immunol. 1996, 156, 2558–2565.
[132] Wilson SJ, Leone BA, Anderson D, Manning A, Holgate ST, J. Pathol. 1999, 189, 265–272.
[133] Molema G, Mesander G, Kroesen BJ, Helfrich W, Meijer DK, de Leij LF, Cytometry 1998, 32,
37–43.
[134] Villaschi S, Nicosia RF, Lab. Invest. 1994, 71, 291–299.
[135] Horizoe T, Nagakura N, Chiba K, Shirota H, Shinoda M, Numata H, Kobayashi S, Abe C, Inflamm.
Res. 1999, 48, 432–436.
[136] Konigsberg PJ, Debrick JE, Pawlowski TJ, Staerz UD, Biochim. Biophys. Acta 1999, 1421,
149–162.